Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human... see more

TSXV:CZO - Post Discussion

Ceapro Inc > Price action
View:
Post by boazklinghorn on Apr 13, 2023 10:11am

Price action

Good news is every time the price gets past 60 the bid gets hit hard so without some kind of news we are going to be in the 50s or maybe lower come AGM day. Shareholder value baby! Coincidentally  today's shareholder value is exactly the same shareholder value as we had in April 2016. 7 freaking years ago and it will be less come AGM day. Dont forget to vote for the man who brought you this fantastic return.
Comment by prophetoffactz on Apr 13, 2023 10:36am
Everyone sees the price. Why not write up a post about the fibrosis opportunity that is before a clinical trial decision. Will it be a stand alone? What's the potential value? What evidence supports CZO's path? With the potential imminent start of the avenanthramide clinical trial why not write up a deep dive into this asset and its potential and scientific support? Avenanthramide is the ...more  
Comment by boazklinghorn on Apr 13, 2023 11:16am
Because I am tired of the endless shoulda coulda woulda. Every single one of the things you mention are years from revenue and in no way a lock to reach commercialization. . We have been down this road with other things and we all know how that went. Always the next thing is going to be the thing. It floors me that you were looking forward to an update on the PGX build out and what did you get ...more  
Comment by boazklinghorn on Apr 13, 2023 11:29am
AS for the science I honestly dont give a Shyt about that. I have been doing this long enough to know that the kind of super preliminary lab results like the Fibrosis study almost never amount to anything. The chances of a viable treatment being discovered even in the hands of a competent Pharmaco are vanishingly small and can take a decade to achieve. CZO doesnt have the cash or the expertise to ...more  
Comment by prophetoffactz on Apr 13, 2023 1:32pm
"The chances of a viable treatment being discovered even in the hands of a competent Pharmaco are vanishingly small and can take a decade to achieve." The key is that you don't pay for it. The pipeline isn't priced into the stock. You get the upside of billion dollar markets for free.  The avenanthramide pill has now been successfully developed and has been approved for ...more  
Comment by prophetoffactz on Apr 13, 2023 11:41am
"Every single one of the things you mention are years from revenue and in no way a lock to reach commercialization." Can drugs be worth a lot more money with human safety/tolerability, and efficacy data than without? CZO has yet to release even preclinical data for its avenanthramide pill and fibrosis drug. Health Canada has approved a clinical trial plan through to the collection of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities